Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bridges

Showing results (421-430 of 588) with videos related to

Pageof 59
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretionA K Singh, B D Schultz, J A Katzenellenbogen, et al.
Prostaglandins & Other Lipid Mediators|November 24, 1999
Secretion of progesterone, estradiol-17beta, PGE, PGF2alpha, and pregnancy-specific protein B by 90-day intact and ovariectomized pregnant ewesY S Weems, P J Bridges, B R LeaMaster, et al.
Prostaglandins & Other Lipid Mediators|November 24, 1999
Effect of prostaglandin F2alpha (PGF2alpha), indomethacin, tamoxifen or estradiol-17beta on prostaglandin E (PGE), PGF2alpha and estradiol-17beta secretion in 88 to 90-day pregnant sheepP J Bridges, Y S Weems, L M Kim, et al.
The Biochemical Journal|May 16, 2009
Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membraneAndrew Young, Martina Gentzsch, Cynthia Y Abban, et al.
European Journal of Pharmacology|January 19, 1988
Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acidR J Bridges, M M Kadri, D T Monaghan, et al.
Molecular Pharmacology|January 20, 2007
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomesDaniel J Bridges, Matthew K Gould, Barbara Nerima, et al.
Physiological Reports|September 13, 2021
Mechanistic analysis and significance of sphingomyelinase-mediated decreases in transepithelial CFTR currents in nHBEsKirsten A Cottrill, Vincent D Giacalone, Camilla Margaroli, et al.
Journal of Medicinal Chemistry|July 1, 1988
N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptorA J Bridges, R F Bruns, D F Ortwine, et al.
Reproductive Biomedicine Online|June 14, 2011
Methodology matters: IVF versus ICSI and embryonic gene expressionPhillip J Bridges, Myoungkun Jeoung, Heyoung Kim, et al.
Families, Systems & Health : the Journal of Collaborative Family Healthcare|June 16, 2017
Need, access, and the reach of integrated care: A typology of patientsAna J Bridges, Bianca T Villalobos, Elizabeth A Anastasia, et al.
Pageof 59

Showing results (421-430 of 588) with videos related to

Sort By:
Pageof 59
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretionA K Singh, B D Schultz, J A Katzenellenbogen, et al.
Prostaglandins & Other Lipid Mediators|November 24, 1999
Secretion of progesterone, estradiol-17beta, PGE, PGF2alpha, and pregnancy-specific protein B by 90-day intact and ovariectomized pregnant ewesY S Weems, P J Bridges, B R LeaMaster, et al.
Prostaglandins & Other Lipid Mediators|November 24, 1999
Effect of prostaglandin F2alpha (PGF2alpha), indomethacin, tamoxifen or estradiol-17beta on prostaglandin E (PGE), PGF2alpha and estradiol-17beta secretion in 88 to 90-day pregnant sheepP J Bridges, Y S Weems, L M Kim, et al.
The Biochemical Journal|May 16, 2009
Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membraneAndrew Young, Martina Gentzsch, Cynthia Y Abban, et al.
European Journal of Pharmacology|January 19, 1988
Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acidR J Bridges, M M Kadri, D T Monaghan, et al.
Molecular Pharmacology|January 20, 2007
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomesDaniel J Bridges, Matthew K Gould, Barbara Nerima, et al.
Physiological Reports|September 13, 2021
Mechanistic analysis and significance of sphingomyelinase-mediated decreases in transepithelial CFTR currents in nHBEsKirsten A Cottrill, Vincent D Giacalone, Camilla Margaroli, et al.
Journal of Medicinal Chemistry|July 1, 1988
N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptorA J Bridges, R F Bruns, D F Ortwine, et al.
Reproductive Biomedicine Online|June 14, 2011
Methodology matters: IVF versus ICSI and embryonic gene expressionPhillip J Bridges, Myoungkun Jeoung, Heyoung Kim, et al.
Families, Systems & Health : the Journal of Collaborative Family Healthcare|June 16, 2017
Need, access, and the reach of integrated care: A typology of patientsAna J Bridges, Bianca T Villalobos, Elizabeth A Anastasia, et al.
Pageof 59